T1	Participants 0 111	The treatment of localized non-Hodgkin's lymphoma in children: a report from the Children's Cancer Study Group.
T2	Participants 172 183	73 children
T3	Participants 220 270	non-Hodgkin's lymphoma on a prospective randomized
T4	Participants 459 602	All patients received central nervous system prophylaxis with intrathecal methotrexate and most received local or regional radiation treatment.
T5	Participants 830 867	Histopathology was reviewed centrally
T6	Participants 1003 1063	Patients with localized lymphoblastic disease were uncommon.
T7	Participants 807 829	four died of toxicity.
T8	Participants 1164 1362	COMP is an excellent treatment for patients with localized disease of nonlymphoblastic type, but the relative value of the two regimens for patients with localized lymphoblastic disease is uncertain
T9	Participants 331 393	(cyclophosphamide, vincristine, methotrexate, prednisone [COMP
